184 results
Page 4 of 10
8-K
EX-10.1
jydiux57jp
13 Mar 20
Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market
4:44pm
8-K
EX-99.1
qj4jgsty
13 Mar 20
Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market
4:44pm
424B5
bhzf6abm
10 Mar 20
Prospectus supplement for primary offering
3:04pm
8-K
EX-10.2
4l6gx22rhah
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
8-K
EX-99.1
xqfz4kmx
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
8-K
EX-10.1
c0swxndo
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
424B5
tu5b55fd mivfagebc4
28 Feb 20
Prospectus supplement for primary offering
1:27pm
424B5
eguwz2e6r45e0xngtta8
31 Jan 20
Prospectus supplement for primary offering
8:03am
8-K
EX-10.1
dpfro
31 Jan 20
Entry into a Material Definitive Agreement
8:01am
8-K
EX-1.1
tyj4dddoewh78l3jp9
31 Jan 20
Entry into a Material Definitive Agreement
8:01am
424B5
xl3sr90g5wvnncf 05
31 Jan 20
Prospectus supplement for primary offering
8:01am
424B5
i7y j6imx4i
31 Oct 19
Prospectus supplement for primary offering
4:05pm
424B5
3jsjscy
31 Oct 19
Prospectus supplement for primary offering
4:02pm
8-K
EX-1.1
27yae1bj
31 Oct 19
Entry into a Material Definitive Agreement
9:29am
8-K
EX-99.1
nyhma6p7 v2yz
30 Oct 19
Cocrystal Pharma, Inc. Announces Proposed Underwritten Public Offering of Common Stock
5:09pm
424B5
z39 ptf6p7u4sf
30 Oct 19
Prospectus supplement for primary offering
4:59pm
8-K
EX-1.1
vzgdabmm97l9 gf4vd0u
30 Oct 19
Entry into a Material Definitive Agreement
4:38pm